04:12 PM EDT, 08/22/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on August 20, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $410,638. Following the Form 4 filing with the SEC, Malik has control over a total of 125,004 shares of the company, with 125,004 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224022777/xslF345X05/form4.xml